Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absent, aforementioned, Albuferon, allege, alleged, alleging, analyzed, appealing, ascending, assumption, award, Bayer, Benefical, Boston, BRIT, budget, Carolina, CED, cediranib, Celldex, cilengitide, complaint, condensed, CT, CTL, daily, decline, deficiency, demostrated, disputed, encompassing, fifteen, GAAP, GCP, gemcitabine, great, guided, Harmonization, ICH, immunocytokine, immunosuppressive, improperly, India, ineffective, infrequent, interfered, interfering, kilogram, led, lessen, load, log, MAb, melanoma, microbubble, mild, missile, MRI, Nexavar, nil, Orange, outsourcing, ovary, peak, peptide, pharmacologic, point, precision, predicated, problematic, proportion, RECIST, recovered, relapse, replase, repurchase, RNA, robust, saving, secret, serum, simplified, slightly, South, stressful, technique, telaprevir, transient, ultrasound, undefined, undergoing, unrecognized, vaccine, valopicitabine, Vectibix, violation, weekly, yield
Removed:
abnormal, allocated, allocation, antidilutive, attendance, attributed, canceled, closely, conversion, converted, create, detachable, earliest, embedded, EMEA, Equiplace, exploring, feature, finder, forced, guidance, implementation, injected, interim, issuable, Medicinal, merged, negotiated, NeoPharm, panitumumab, paper, plc, prominent, quotient, resale, rollforward, SPA, split, tarvacin, transition, TransMID, unamortized, unique, unused, voluntary, Xenova
Filing tables
Filing exhibits
Related press release
CDMO similar filings
Filing view
External links
EXHIBIT 21
PEREGRINE PHARMACEUTICALS, INC.
Subsidiaries of Registrant
During January 2002, the Company announced the formation of Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc.
On April 24, 1997, the Company acquired its wholly owned subsidiary, Vascular Targeting Technologies, Inc. (formerly known as Peregrine Pharmaceuticals, Inc.).
On August 28, 2006, the Company established a wholly owned subsidiary, Peregrine (Beijing) Pharmaceutical Technology Ltd. in the Haidian District, Beijing, Peoples Republic of China.